Abstract
Pluripotent stem cells (PSCs) are a useful source of cells for exploring the role of genes related with early developmental processes and specific diseases due to their ability to differentiate into all somatic cell types. Recently, the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system has proven to be a robust tool for targeted genetic modification. Here, we generated miR-451-deficient PSCs using the CRISPR/Cas9 system with PCR-based homologous recombination donor and investigated the impact of its deletion on self-renewal and hematopoietic development. CRISPR/Cas9-mediated miR-451 knockout did not alter the gene expressions of pluripotency, cellular morphology, and cell cycle, but led to impaired erythrocyte development. These findings propose that a combination of PSCs and CRISPR/Cas9 system could be useful to promote biomedical applications of PSCs by elucidating the function and manipulating of specific miRNAs during lineage specification and commitment.
Similar content being viewed by others
References
Romito A, Cobellis G. Pluripotent stem cells: current understanding and future directions. Stem Cells Int. 2016. doi:10.1155/2016/9451492
Ireland RG, Simmons CA. Human pluripotent stem cell mechanobiology: manipulating the biophysical microenvironment for regenerative medicine and tissue engineering applications. Stem Cells. 2015;33:3187–96.
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
Lee YJ, Ramakrishna S, Chauhan H, Park WS, Hong SH, Kim KS. Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency. Cell Regen (Lond). 2016;5:2.
Jin HL, Kim JS, Kim YJ, Kim SJ, Broxmeyer HE, Kim KS. Dynamic expression of specific miRNAs during erythroid differentiation of human embryonic stem cells. Mol Cells. 2012;34:177–83.
Bhin J, Jeong HS, Kim JS, et al. PGC-enriched miRNAs control germ cell development. Mol Cells. 2015;38:895–903.
Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819–23.
Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823–6.
Wang H, Yang H, Shivalila CS, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 2013;153:910–8.
Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157:1262–78.
Heo YT, Quan X, Xu YN, et al. CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells. Stem Cells Dev. 2015;24:393–402.
Renneville A, Van Galen P, Canver MC, et al. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. Blood. 2015;126:1930–9.
Ru R, Yao Y, Yu S, et al. Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs. Cell Regen (Lond). 2013;2:5.
Yan Q, Zhang Q, Yang H, et al. Generation of multi-gene knockout rabbits using the Cas9/gRNA system. Cell Regen (Lond). 2014;3:12.
Zhu S, Rong Z, Lu X, Xu Y, Fu X. Gene targeting through homologous recombination in monkey embryonic stem cells using CRISPR/Cas9 system. Stem Cells Dev. 2015;24:1147–9.
Huang K, Du J, Ma N, et al. GATA2(–/–) human ESCs undergo attenuated endothelial to hematopoietic transition and thereafter granulocyte commitment. Cell Regen (Lond). 2015;4:4.
Harrison MM, Jenkins BV, O’Connor-Giles KM, Wildonger J. A CRISPR view of development. Genes Dev. 2014;28:1859–72.
Liao J, Karnik R, Gu H, et al. Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells. Nat Genet. 2015;47:469–78.
Song B, Fan Y, He W, et al. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system. Stem Cells Dev. 2015;24:1053–65.
Tan EP, Li Y, Velasco-Herrera Mdel C, Yusa K, Bradley A. Off-target assessment of CRISPR-Cas9 guiding RNAs in human iPS and mouse ES cells. Genesis. 2015;53:225–36.
Zhou HY, Katsman Y, Dhaliwal NK, et al. A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential. Genes Dev. 2014;28:2699–711.
Ma Y, Yao N, Liu G, et al. Functional screen reveals essential roles of miR-27a/24 in differentiation of embryonic stem cells. EMBO J. 2015;34:361–78.
Dore LC, Amigo JD, Dos Santos CO, et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA. 2008;105:3333–8.
Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech. 2013;24:224–31.
Ran FA, Hsu PD, Lin CY, et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013;154:1380–9.
Sagi D, Tlusty T, Stavans J. High fidelity of RecA-catalyzed recombination: a watchdog of genetic diversity. Nucl Acids Res. 2006;34:5021–31.
Lesinski DA, Heinz N, Pilat-Carotta S, et al. Serum- and stromal cell-free hypoxic generation of embryonic stem cell-derived hematopoietic cells in vitro, capable of multilineage repopulation of immunocompetent mice. Stem Cells Transl Med. 2012;1:581–91.
Fennell M, Xiang Q, Hwang A, et al. Impact of RNA-guided technologies for target identification and deconvolution. J Biomol Screen. 2014;19:1327–37.
Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ. miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood. 2009;113:1794–804.
Papapetrou EP, Korkola JE, Sadelain M. A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells. Stem Cells. 2010;28:287–96.
Patrick DM, Zhang CC, Tao Y, et al. Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev. 2010;24:1614–9.
Rasmussen KD, Simmini S, Abreu-Goodger C, et al. The miR-144/451 locus is required for erythroid homeostasis. J Exp Med. 2010;207:1351–8.
Yu D, dos Santos CO, Zhao G, et al. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev. 2010;24:1620–33.
Kouhkan F, Soleimani M, Daliri M, et al. miR-451 up-regulation, induce erythroid differentiation of CD133+ cells independent of cytokine cocktails. Iran J Basic Med Sci. 2013;16:756–63.
Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ. MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol. 2007;35:1015–25.
Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun. 2007;364:509–14.
Acknowledgements
This study was supported by a grant from the Medical Research Center (2008-0062287) and the Basic Research Lab Program (2015R1A4A1038666) funded by the NRF of the Ministry of Science, ICT & Future Planning, Republic of Korea.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no financial conflicts of interest.
Ethical statement
There are no human or animal experiments carried out for this article.
Additional information
Su-Jin Kim and Chang-Hoon Kim have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kim, SJ., Kim, CH., An, B. et al. Effects of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system-Based Deletion of miR-451 in Mouse Embryonic Stem Cells on Their Self-Renewal and Hematopoietic Differentiation. Tissue Eng Regen Med 14, 179–185 (2017). https://doi.org/10.1007/s13770-017-0031-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-017-0031-8